In-silico Analysis of Terpenes From Mentha rotundifolia (L) As Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors
Article Sidebar
-
ACE2, Inhibition, In-silico, Lisinopril, Mentha rotundifolia, terpenes
Abstract
The Mentha genus includes several species such as Mentha rotundifolia L., which is widely distributed around the Mediterranean basin, America and in western Asia. The plant is recommended in folk medicine for the treatment of various diseases. It has also been used to discover biomolecules that have significant beneficial effects with fewer side effects. Mentha rotundifolia (L) leaves are potential as an antihypertensive cause of terpenes which contain in them. 36 different terpenes and terpenoids have been identified and selected from this plant. This study evaluated the mechanism of phytoconstituents from the above plant in the inhibition of angiotensin-converting enzyme-related carboxypeptidase (ACE2) with molecular docking. Selected ligands were docked on the receptor (PDB ID: 1R4L) using Auto Dock Vina and analysed by PyMol. 2D and 3D structures of compounds were drawn by the Chem Draw program. The standard drug that has been taken for the study, lisinopril, has shown a binding affinity of -7.8 Kcal/mol. Calacorene, one of the terpenes present in the plant, has interacted with Phe274, Asp367, Glu406, Thr445, Thr371 residues of protein and produced a docking score similar to that of the standard drug Lisinopril. In the light of the results obtained, the plant studied is promising as a source of natural hypotensive agent that can be further developed as a lead molecule.
Full text article
References
Awang, D. V. 1999. Tyler’s herbs of choice: The Therapeutic Use of Phytomedicinals. CRC Press, third edition.
Balakrishnan, A. 2015. Therapeutic Uses of Peppermint-A Review. Journal of Pharmaceutical Science and Research, 7(7):474–476.
Brada, M., Bezzina, M., Marlier, M., Lognay, G. C. 2006. Chemical Composition of the Leaf Oil of Mentha rotundifolia (L.) from Algeria. Journal of Essential Oil Research, 18(6):663–665.
Hawthorn, M., Ferrante, J., Luchowski, E., Rutledge, A., Wei, X. Y., Triggle, D. J. 1988. The actions of peppermint oil and menthol on calcium channel-dependent processes in intestinal, neuronal and cardiac preparations. Alimentary Pharmacology and Therapeutics, 2(2):101–118.
Mikaili, P., Mojaverrostami, S., Moloudizargari, M., Aghajanshakeri, S. 2013. Pharmacological and therapeutic effects of Mentha Longifolia L. and its main constituent, menthol. Ancient Science of Life, 33(2):131–138.
Pattnaik, S., Subramanyam, V. R., Bapaji, M., Kole, C. R. 1997. Antibacterial and antifungal activity of aromatic constituents of essential oils. Microbios, 89(358):39–46.
Shahbazi, Y. 2015. Chemical Composition and In Vitro Antibacterial Activity of Mentha spicata Essential Oil against Common Food-Borne Pathogenic Bacteria. Journal of Pathogens, 2015:1–5.
Sidorenkov, G., Navis, G. 2014. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opinion on Drug Safety, 13(10):1383–1395.
Singh, R., Shushni, M. A., Belkheir, A. 2015. Antibacterial and antioxidant activities of Mentha piperita L. Arabian Journal of Chemistry, 8(3):322–328.
Towler, P., Staker, B., Prasad, S. G., Menon, S., Tang, J., Parsons, T. 2004. ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis. Journal of Biological Chemistry, 279(17):17996–18007.
Wang, G., Tang, W., Bidigare, R. R. 2005. Terpenoids as Therapeutic Drugs and Pharmaceutical Agents. Natural Products, Humana Press Inc, Totowa, New Jersey.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.